Sandoz Industrial Products Sa, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for A global leader in antibiotics.
One of their notable products is AMOXCILLIN TRIHYDRATE USP, with a corresponding US DMF Number 13764.
Remarkably, this DMF maintains an Active status since its submission on September 01, 1998, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 13, 2019, and payment made on August 09, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II